Molecular mechanisms of dragon’s blood in treating ulcerative colitis based on NF-κb/NLPR3/Caspase-1 pyroptosis signaling pathway
PLOS One · 2025
DOI: 10.1371/journal.pone.0331570 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Bilian Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi University of Chinese Medicine, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: NF-kappa B, Caspase 1, Colitis, Ulcerative, Pyroptosis. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To elucidate the molecular mechanism of dragon’s blood (DB) in the treatment of ulcerative colitis (UC).
Methods
Bioactive metabolites of DB absorbed into the bloodstream were characterized via LC-MS. Network pharmacology and molecular docking were employed to construct a target-pathway interaction model predicting DB’s therapeutic mechanism in UC. A 4% DSS-induced UC mouse model was used for experimental validation.
Results
DB markedly alleviated colonic injury in DSS-induced UC. A total of 255 active compounds were identified, including 6,4’-Dimethoxy-7-hydroxyisoflavone, 7-hydroxy-2-(4-methoxyphenyl) chromen-4-one, and Apigenin. Key molecular targets included NLPR3, MAPK1, TP53, HIF1A, and PTGS2. The NF-κB/NLPR3/Caspase-1 axis was implicated as a central pathway mediating the therapeutic effects of DB.
Conclusion
DB acts through a multi-component, multi-target, and multi-pathway strategy. Inhibiting the NF-κB/NLPR3/Caspase-1 pyroptosis pathway positions NLPR3 as a viable target for DB in UC intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
- First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
ORCID-Profile: Bilian Cai, Yilei Wen
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Cai, B., Qin, X., Huang, X., He, X., Zhong, H., Yu, Y., Cui, J., & Wen, Y. (2025). Molecular mechanisms of dragon’s blood in treating ulcerative colitis based on NF-κb/NLPR3/Caspase-1 pyroptosis signaling pathway. PLOS One. https://doi.org/10.1371/journal.pone.0331570
Vancouver
Cai B, Qin X, Huang X, He X, Zhong H, Yu Y, et al. Molecular mechanisms of dragon’s blood in treating ulcerative colitis based on NF-κb/NLPR3/Caspase-1 pyroptosis signaling pathway. PLOS One. 2025. doi:10.1371/journal.pone.0331570
BibTeX
@article{Cai2025,
author = {Cai, Bilian and Qin, Xiaohua and Huang, Xiaogang and He, Xiaojin and Zhong, Huanying and Yu, Yuan and Cui, Jinzhu and Wen, Yilei},
title = {Molecular mechanisms of dragon’s blood in treating ulcerative colitis based on NF-κb/NLPR3/Caspase-1 pyroptosis signaling pathway},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0331570}
}
EUVIMED